Search Results
851 results
Your search is now limited to «Lung Cancer» expert search. 03/20/2019 18:07
A protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis, according to new research.
More from
Oncology Central 03/20/2019 11:53
The post Novel analysis technique could improve accuracy of detecting cancerous DNA in lung cancer appeared first on Oncology Central.
More from Oncology Central: 03/20/2019 10:36
Conditions : Exercise; Neoplasms Intervention : Device: Telecoaching Sponsor : KU Leuven Enrolling by invitation.
More from 03/20/2019 09:26
New method could detect tiny fragments of cancerous genetic material in the blood of lung cancer patients precisely by determining the sequence of molecules in DNA, according to a research published in the cancer journal Annals of Oncology.
More from
PR Newswire 03/20/2019 08:32
We want a person with mesothelioma or asbestos exposure lung cancer to receive the best possible financial compensation - it is for this reason we suggest the law firm of Karst von Oiste.
More from PR Newswire:
Pharmafile 03/20/2019 06:38
Roche's Tecentriq chalks up another FDA approval, this time in first-line extensive-stage small cell lung cancer.
More from Pharmafile:
Nature 03/20/2019
Neoantigen-directed immune escape in lung cancer evolution. Neoantigen-directed immune escape in lung cancer evolution, Published online: 20 March 2019; doi:10.1038/s41586-019-1032-7. RNA sequencing data and tumour pathology observations of non-small-cell lung cancers indicate that the immune cell microenvironment exerts strong evolutionary selection pressures that shape the immune-evasion capacity of tumours.
Targeting RET-rearranged non-small-cell lung cancer: future prospects.
More from International Journal of COPD: 03/19/2019 11:56
Tecentriq is already approved for the treatment of patients with advanced bladder cancer, advanced lung cancer and in combination with Avastin and chemotherapy for the preliminary treatment of people with metastatic non-squamous NSCLC.
More from
ecancer news 03/19/2019 10:13
FDA approves atezolizumab for extensive-stage small cell lung cancer.
More from ecancer news:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications